BRXCX
Price
$20.19
Change
+$0.09 (+0.45%)
Updated
Aug 25 closing price
Net Assets
6.09B
FSGEX
Price
$21.55
Change
+$0.18 (+0.84%)
Updated
Aug 25 closing price
Net Assets
74.78B
Interact to see
Advertisement

BRXCX vs FSGEX

BRXCX vs FSGEX Comparison Chart in %
View a ticker or compare two or three
VS
BRXCX vs. FSGEX commentary
Aug 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXCX is a Buy and FSGEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 74.8B vs. BRXCX (6.09B). FSGEX pays higher dividends than BRXCX: FSGEX (2.66) vs BRXCX (0.89). BRXCX was incepted earlier than FSGEX: BRXCX (11 years) vs FSGEX (17 years). BRXCX (1.53) is less costly to investors than FSGEX (0.01). BRXCX is a more actively managed with annual turnover of: 48.00 vs. FSGEX (8.00). FSGEX has a lower initial minimum investment than BRXCX: FSGEX (0) vs BRXCX (1000). BRXCX (27.34) and FSGEX (26.49) have marching annual gain over last year. BRXCX (60.96) and FSGEX (59.33) have equivalent 5 years return.
BRXCXFSGEXBRXCX / FSGEX
Total Expense Ratio1.520.0115,200%
Annual Report Gross Expense Ratio1.530.0115,300%
Fund Existence11 years17 years-
Gain YTD18.79416.776112%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.09B74.8B8%
Annual Yield % from dividends0.892.6634%
Returns for 1 year27.3426.49103%
Returns for 3 years87.4877.02114%
Returns for 5 years60.9659.33103%
Returns for 10 years132.62136.7697%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPHA2.270.05
+2.25%
Innate Pharma SA
BN42.120.15
+0.36%
Brookfield Corporation
ABCB85.54-0.41
-0.48%
Ameris Bancorp
CLBK11.65-0.13
-1.15%
Columbia Financial
BTLN0.94-0.01
-1.30%
Brightline Interactive Inc